CCMI
KRYS icon

Creative Capital Management Investments’s Krystal Biotech KRYS Stock Holding History

Creative Capital Management Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Buy
+3
New +$896 ﹤0.01% 1070

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Creative Capital Management Investments's KRYS Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Krystal Biotech (KRYS) in Q2 2026: 3 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #1070 among its holdings.

74 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Creative Capital Management Investments held 3 shares of Krystal Biotech worth $1.11K as of Q2 2026.
  • Krystal Biotech was a new Creative Capital Management Investments position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1070 holding.
  • 74 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.